| 05-Aug-2016 | S | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 05, 2016, have approved the sub-division of existing Equity Shares of face value Rs. 10/- each into 5 (five) Equity Shares of face value of Rs. 2/- each, subject to the approval of members of the Company at the ensuing Annual General Meeting and Regulatory/ Statutory approvals.
Trading Members of the Exchange are hereby informed that, Caplin Point Laboratories Ltd. has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Caplin Point Laboratories Ltd.
(524742)
RECORD DATE
20/10/2016
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
19/10/2016 DR-137/2016-2017
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 19/10/2016.
ii. ISIN No. INE475E01018 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 19/10/2016.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 06.10.2016) | 20-Oct-2016 | |
| 07-Aug-2023 | D | Board approved:
1. Recommended a Final Dividend of INR. 2.5 (125%) per equity share of Rs.2 each for the financial year ended March 31, 2023. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting. | 14-Sep-2023 | |
| 27-May-2023 | D | we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following:
Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023.
Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend. | 09-Jun-2023 | |
| 05-Aug-2022 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 05, 2022, inter alia, has recommended a Final Dividend of Rs. 2 (100%) per equity share of Rs. 2 each for the financial year ended March 31, 2022. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting.
Outcome of Board meeting & Intimation of Book Closure and Record Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(As Per BSE Announcement dated on 05.09.2022) | 21-Sep-2022 | |
| 12-May-2022 | D | Declaration of Interim Dividend of Rs.2/- (100%) for the Financial Year 2021-22 | 23-May-2022 | |
| 05-Aug-2021 | D | Recommended a Final Dividend of Rs. 1.50/- (75 %) per equity share of Rs.2 each for the financial year ended 31st March 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting.
| 20-Sep-2021 | |
| 06-May-2021 | D | Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2021, inter alia, has declared an Interim Dividend of Rs. 1.50/- (75%) per equity share of Rs. 2 each for the financial year ended March 31, 2021. | 18-May-2021 | |
| 18-Jun-2020 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2020, inter alia, has recommended a final dividend of Rs. 0.40 paise (20%) per equity share of Rs. 2 each for the financial year ended March 31, 2020. | 21-Sep-2020 | |
| 04-Mar-2020 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on March 04, 2020, inter alia, have approved the payment of Interim Dividend of Rs. 2.10 paise (105%) per equity share of Rs. 2/- each for the financial year 2019-2020.
Interim Dividend will be paid to the shareholders on or before March 25, 2020. | 12-Mar-2020 | |
| 22-May-2019 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 22, 2019, inter alia, has recommended a dividend of Rs. 2.20 (110%) per equity share of Rs. 2/- each for the financial year ended March 31, 2019. | 04-Sep-2019 | |
| 28-May-2018 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, have recommended a dividend of Rs. 2 (Rupees Two) (100%) per equity share of Rs.2/- each for the financial year ended March 31, 2018. | 18-Sep-2018 | |
| 11-May-2017 | D | The Board of Directors of the Company at their meeting held today, May 10,2017, have recommended a Dividend of 75% (i.e) Rs. 1.50 paise per equity share at the face value of Rs.2 each for the financial year ended March 31,2017 | 07-Sep-2017 | |
| 27-May-2016 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, have recommended a Final Dividend of Rs. 3.50 (35%) on the face value of Rs. 10 each for Nine months/Financial Year ended March 31, 2016. | 01-Sep-2016 | |
| 05-Feb-2016 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 05, 2016, inter alia, have:
Declared an Interim Dividend of Rs. 2.50 per share (25%) for the financial year 2015-16 on the paid-up capital of Rs. 15.11 Crores represented by 1,51,10,000 equity shares of Rs. 10/- each. | 15-Feb-2016 | |
| 20-Aug-2015 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 20, 2015, inter alia, have:
Recommended dividend of Rs.5 (Rupees five only) (50%) per equity share of Rs.10/- each (fully paid-up) for the financial year ended June 30, 2015 subject to the approval of the shareholders. | 29-Oct-2015 | |
| 25-Aug-2014 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 25, 2014, inter alia, has considered and approved the following:
- Recommendation of final dividend of Rs. 4.00 (Rupees Four only) per share (40%) on the equity capital of Rs. 10/- each for the year ended June 30, 2014 subject to the approval of the Shareholders in the ensuing Annual General Meeting. | 11-Dec-2014 | |
| 16-Aug-2013 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 16, 2013, inter alia, has considered and approved the recommendation of final dividend of Rs. 2.50 (Rupees Two and Paise Fifty only) per share (25%) on the equity capital of Rs. 10/- each for the year ended June 30, 2013 subject to the approval of the Shareholders in the ensuing Annual General Meeting. | 19-Dec-2013 | |
| 12-Nov-2012 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09, 2012, inter alia, has recommended dividend a final dividend of Rs. 2/- (Rupees Two only) per share (20%) on the equity capital for the year ended June 30, 2012. | 11-Dec-2012 | |
| 21-Nov-2011 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 21, 2011, inter alia, has Recommended a final Dividend of Re. 1.50 per share (15%) on the equity capital for the year ended June 30, 2011. | 12-Dec-2011 | |
| 22-Nov-2010 | D | Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 22, 2010, inter alia, taken the following decisions :
1. Recommended a final dividend of Re. 1/- per share (10%) on the equity capital for the year ended June 30, 2010. | 09-Dec-2010 | |
| 30-Jan-2024 | BC | CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the un-audited financial results | 09-Feb-2024 | |
| 28-Dec-2023 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Friday | 29-Dec-2023 | |
| 01-Nov-2023 | BC | CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the un-audited financial results | 09-Nov-2023 | |
| 11-Oct-2023 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd | 12-Oct-2023 | |
| 07-Aug-2023 | BC | Intimation of Book Closure and Record date pursuant to Regulation 42 of the SEBI Lisitng Regulations.
Re-appointment of Dr.C K Gariyali (DIN 08711546) as an Independent Director of the company.
| 21-Sep-2023 | |